Contract research organisation (CRO) Quintiles gained new ‘first-in-human’ (FIH) trial capacity yesterday with the opening of an ‘experimental medicine hub’ at Guy’s Hospital in London, UK.
Gerresheimer has bought Brazilian pharmaceutical plastic packaging maker Vedat, citing rapid growth of the country’s drug market, particularly the generics segment, as the main driver for the acquisition.
ShangPharma said it saw revenue climb on higher customer spending in the fourth quarter, but that margins slid due to currency effects and higher share-based compensation.
Contract services firm Almac aims to expand its trial patient management and compliance offering though a new partnership with ePRO specialist Exco InTouch.
Next month the United Nations Conference on Trade and Development (UNCTAD) will organise a meeting to discuss ways of encouraging the production of pharmaceutical in Africa.
The EMA and the US FDA will conduct parallel assessment of QbD development and manufacturing data for new drug submissions under a new pilot scheme announced this week.
World Street Fundamentals (WSF), the financial research specialist, has released two industry reports highlighting the mixed fortunes of biotech firms Biodel and MannKind, but claims a “brighter decade” lies ahead for the biotech sector.
Don’t think of the global regulatory information clampdown as a burden. It’s an opportunity to put your house in order, says Adam Sherlock, MD of ISI Europe.
Informed Medical Communications (IMC) a healthcare communications and training provider, has merged with training program designer and developer, IC Axon.
Leading players in the Japanese contract research sector have predicted ongoing disruption to trials in the aftermath of the massive earthquake and tsunami that struck the country last week.
US drug giant Pfizer may sell its generics, consumer health and Capsugel units in an effort to slim down and refocus on its core pharmaceutical business according to a number of reports.
Applying a business model based on marketing theory to clinical trials can give a consistent framework for planning and managing patient recruitment, say academics.
SOCMA and the EFCG want the US FDA to make inspection of overseas API manufacturing sites mandatory, with the facilities paying for the costs themselves.
CRO and Pharma patient recruitment efforts can benefit from social networks and online patient groups, but clarification from the US FDA is still needed.
The Japanese drug sector seems to have survived the earthquake and tsunami that struck the country largely unscathed, with early reports suggesting that most manufacturing sites have escaped damage.
Wuxi PharmaTech finished the fourth quarter and the full year 2010 on a high driven by growth across all business units and the payoff from former suitor Charles River Laboratories (CRL).
Regional production hubs created by technology transfer can improve public health and drive economic development in low- to mid-income countries, says Eli Lilly
US healthcare giant Johnson & Johnson (J&J) has recalled 384,000 of its insulin cartridges on concerns the products could cause serious health problems for diabetics.
GEA Pharma Systems, the German drug processing equipment manufacturer, has signed a representation agreement with Swedish hi-tech firm Christian Berner Tech Trade.
Thermo Fisher Scientific has launched a predictive assay that, it claims, can assess a drug candidate’s potential to cause liver damage earlier than traditional methods.
CSM GlobalPharma has announced plans to invest $65m in a manufacturing facility in Kigali, Rwanda in collaboration with the Rwandan Development Board (RDB).
US CRO Celerion is to expand in-house compounding for microtracer studies after gaining certification for cleanroom and pharmacists at its Ph I unit in Lincoln, Nebraska.
Warnex will provide central laboratory services for Genzyme Canada as part of the US biotech’s lysosomal storage disease (LSD) testing programme in Canada.
Contract research organisation (CRO) Maccine will set up a preclinical imaging laboratory in partnership with the Singapore Bioimaging Consortium (SBIC) under a deal announced late last week.